Al-Thani Hassan, Al-Thani Noora, Al-Sulaiti Maryam, Tabeb Abdelhakem, Asim Mohammad, El-Menyar Ayman
Department of Surgery, Hamad General Hospital, Doha, Qatar.
Department of Internal Medicine, Hamad General Hospital, Doha, Qatar.
Front Surg. 2022 Mar 3;9:848565. doi: 10.3389/fsurg.2022.848565. eCollection 2022.
Currently, adrenalectomies are trending toward minimally invasive approach including robotic and laparoscopic surgery. We aimed to describe the clinical presentation and outcomes associated with the 3 different surgical approaches in patients who underwent adrenalectomy for adrenal mass at a single tertiary center.
A retrospective descriptive observational study was conducted to include all patients who underwent surgical interventions for adrenal gland mass between 2004 and 2019. Patients were categorized into three groups according to the interventional approach (open, robotic vs. laparoscopic adrenalectomy) and data were analyzed and compared.
A total of 124 patients underwent adrenalectomies (61.3% robotic, 22.6% open, and 16.1% laparoscopic approach). Incidentally discovered adrenal mass was reported in 67% of patients, and hypertension was the most prevalent comorbidity (53%). The tendency for malignancy increased with increasing tumor size while the functioning tumors were more in the smaller tumor size. Larger tumors were more common in younger patients. The robotic approach showed shorter surgical intensive care and hospital length of stay. Patients in the open adrenalectomy group frequently presented with abdominal pain ( = 0.001), had more nonfunctional adrenal mass ( = 0.04), larger mean tumor size ( = 0.001), and were frequently operated on the right side ( = 0.03). There was no post-operative mortality; however, during follow-up, 8 patients died (3 open, 3 laparoscopic and, 2 robotic approach). The median follow-up was 746 days (range 7-5,840).
The study explored the three surgical adrenalectomy approaches in a dedicated center for patients with adrenal pathology. It showed that robotic adrenalectomy could be safe and effective surgical approach for patients with benign functioning adrenal tumors of a diameter <6 cm. However, the choice of a surgical approach varies according to the adrenal mass presentation, patient fitness for surgery, type and sizes of the tumor, surgeon's experience, and hospital resources. Open surgery is considered the first choice for larger, ruptured adrenal tumor or malignancy. However, the recent restructuring of the surgical department resulted in selection bias in favor of the robotic surgery. Further studies are required to address the risk factors, selection criteria for appropriate management, cost, and quality of life.
目前,肾上腺切除术正趋向于采用包括机器人手术和腹腔镜手术在内的微创方法。我们旨在描述在一家单一的三级中心接受肾上腺肿块肾上腺切除术的患者中,三种不同手术方法的临床表现和结局。
进行了一项回顾性描述性观察研究,纳入2004年至2019年间所有接受肾上腺肿块手术干预的患者。根据干预方法(开放手术、机器人手术与腹腔镜肾上腺切除术)将患者分为三组,并对数据进行分析和比较。
共有124例患者接受了肾上腺切除术(机器人手术占61.3%,开放手术占22.6%,腹腔镜手术占16.1%)。67%的患者报告肾上腺肿块为偶然发现,高血压是最常见的合并症(53%)。恶性倾向随肿瘤大小增加而增加,而功能性肿瘤在较小肿瘤大小中更为常见。较大的肿瘤在年轻患者中更常见。机器人手术方法显示手术重症监护和住院时间更短。开放肾上腺切除术组的患者经常出现腹痛(P = 0.001),无功能肾上腺肿块更多(P = 0.04),平均肿瘤尺寸更大(P = 0.001),且经常在右侧进行手术(P = 0.03)。无术后死亡;然而,在随访期间,8例患者死亡(开放手术3例,腹腔镜手术3例,机器人手术2例)。中位随访时间为746天(范围7 - 5840天)。
该研究在一个专门的肾上腺疾病中心探讨了三种肾上腺切除手术方法。结果表明,对于直径<6 cm的良性功能性肾上腺肿瘤患者,机器人肾上腺切除术可能是一种安全有效的手术方法。然而,手术方法的选择因肾上腺肿块表现、患者手术适应性、肿瘤类型和大小、外科医生经验以及医院资源而异。开放手术被认为是较大的、破裂的肾上腺肿瘤或恶性肿瘤的首选。然而,最近外科科室的重组导致了有利于机器人手术的选择偏倚。需要进一步研究来解决危险因素、适当管理的选择标准、成本和生活质量问题。